发明名称 CANCER THERAPY
摘要 The present application relates to compositions and methods for treating a proliferative disorder by administering to a subject a pharmaceutical composition of a dual kinase inhibitor metabolite. Catecholic butane metabolites can serve as dual kinase inhibitors for purposes of methods described herein. Proliferative diseases are a serious threat to modem society. Cancerous growths, including malignant cancerous growth, pose serious challenges for modem medicine due to their unique characteristics.
申请公布号 CA2941010(A1) 申请公布日期 2014.09.04
申请号 CA20142941010 申请日期 2014.02.26
申请人 TRIACT THERAPEUTICS, INC. 发明人 WHITE, THOMAS F.;SMITH, STEVEN
分类号 A61K31/7034;A61K31/661;A61P35/00;G01N33/48 主分类号 A61K31/7034
代理机构 代理人
主权项
地址